Qiagen's shareholders okay $1.6 billion merger with Digene

July 2007
Medical Device Daily;7/23/2007, Vol. 11, p6
The article announced that Qiagen has received the vote of the necessary percentage of its shareholders in favor of the $1.6 billion acquisition of Digene at its extraordinary general meeting of shareholders held in the Netherlands. The companies reported that they had entered into a merger agreement in which Digene will be acquired by Qiagen in a transaction that consists of 55 percent cash and 45 percent Qiagen stock.


Related Articles

  • Qiagen completes Digene buy; ME buys stroke treatment rights.  // Medical Device Daily;8/1/2007, Vol. 11 Issue 145, p2 

    The article reports on the completion of the acquisition of Digene by Qiagen of the Netherlands. Report says that Qiagen has completed the acquisition through a tender offer and subsequent merger of Digene with and into a wholly owned subsidiary of the company. Under the deal, Digene will become...

  • Qiagen to acquire Digene via cash and stock deal worth $1.6 billion. Johnson, Holland // Diagnostics & Imaging Week;6/7/2007, Vol. 10 Issue 23, p1 

    The article announces the plan of genetic testing equipment manufacturer Qiagen to acquire Digene. Qiagen will acquire Digene through a cash and stock deal amounting to $1.6 billion. Under the deal, shareholders of Qiagen will own 78 percent of the combine company, while Digene shareholders will...

  • Qiagen to buy Digene for $1.6B; Flextronics, Solectron to merge. Johnson, Holland // Medical Device Daily;6/5/2007, Vol. 11 Issue 107, p1 

    The article offers information on acquisition deals in the medical technology industry. Genetic testing equipment manufacturer Qiagen announced its plans to acquire Digene for $1.6 in cash and stock to expand into testing for cervical cancer and sexually transmitted diseases (STD). Flextronics...

  • Deals roundup.  // Medical Device Daily;7/18/2007, Vol. 11 Issue 137, p2 

    The article presents news briefs on the medical devices industry. Qiagen, a provider of sample assay technologies and products, has acquired Digene for $1.6 billion. Quidel has gained exclusive, worldwide licenses to the antiviral resistance microarray-based influenza detection technology and to...

  • Qiagen to acquire Digene.  // European Pharmaceutical Executive;Jul/Aug2007, p9 

    The article reports on the plan of The Netherlands-based biotechnology industry Qiagen NV to acquire 100% of stock of U.S.-based Digene Corp. Both companies have signed a definitive agreement to combine the two companies. The acquisition consideration will consist of cash and Qiagen stock. It is...

  • DxS Acquisition Boosts Qiagen's Portfolio.  // Bioworld Week;9/28/2009, Vol. 17 Issue 39, p4 

    The article reports on the acquisition of DxS Ltd. by Qiagen NV to broaden its companion diagnostics portfolio in Venlo, Netherlands. Qiagen is known for its hundreds of marketed sample and assay products from scientific research and drug development circles. In addition, it also has expanded...

  • Qiagen to purchase Digene for $1.6 billion; IMI buys Cholestech.  // Biomedical Business & Technology;Jul2007, Vol. 30 Issue 7, p26 

    The article reports on acquisition deals in the diagnostic equipment sector. Qiagen of Venlo in the Netherlands has decided to purchase Gaithersburg, Maryland-based Digene to expand into testing for cervical cancer and sexually transmitted diseases. Inverness Medical Innovations of Waltham,...

  • Siemens buys Dade Behring in $7 B consolidation bid.  // Medical Technology & Devices Week;7/30/2007, Vol. 5 Issue 31, p4 

    The article reports on acquisitions in the diagnostics sector. Dade Behring, a provider of clinical laboratory equipment and integrated solutions, will be acquired by Siemens. Digene in Maryland will be acquired by Qiagen. Roche Diagnostics in Germany announced the completion of its acquisition...

  • Thomson Financial Worldwide Mergers & Acquisitions.  // Mergers & Acquisitions Report;6/11/2007, Vol. 20 Issue 23, p5 

    The article focuses on several merger and acquisition deals in the U.S. Diagnostic agents manufacturer Digene Corp. has been acquired by biotechnology firm Qiagen NV. Diagnostic testing kits maker Cholestech Corp. is purchased by Inverness Med Innovations Inc. Private equity firm Elevation...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics